Her program of research focuses on the ethics and politics of biomedical innovation, with a particular focus on 1) research using databanks and real world evidence 2) access to “unproven” interventions and 3) commercialisation and (financial and non-financial) conflict of interest. She uses a combination of empirical and theoretical research methods understand stakeholders’ perspectives and contribute to policymaking and practice.